FDA Approves Updated Covid-19 Vaccines for Expanded Use in Fight Against Variants
Republished with full copyright permissions from The San Francisco Press. As the fall respiratory illness season looms ahead, the FDA has granted regulatory approval for two updated Covid-19 vaccines that leverage messenger RNA (mRNA) technology. This significant development paves the way for the availability of these new shots in the near future. Previously approved for use in adults, Covid-19 vaccines developed by Pfizer and BioNTech, along with Moderna, have received an extension of approval to include their updated versions. While emergency use authorizations for infants aged six months and older, as well as children up to age 17, already existed, … Continue reading FDA Approves Updated Covid-19 Vaccines for Expanded Use in Fight Against Variants

